Chronic Ischemic Left Ventricular Dysfunction. From Pathophysiology to Imaging and its Integration Into Clinical Practice

JACC: Cardiovascular Imaging

Volumn 1, Issue 4, 2008, Pages 536-555

  Rahimtoola, Shahbudin H ^a   Dilsizian, Vasken ^b   Kramer, Christopher M ^c   Marwick, Thomas H ^d   Vanoverschelde, Jean Louis J ^e  

^a Griffith Center   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

heart failure; hibernation; myocardial infarction; myocardial revascularization

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; AMRINONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; DOBUTAMINE; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; LEVOSIMENDAN; POTASSIUM; THALLIUM 201;

ALGORITHM; ANGIOCARDIOGRAPHY; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FUNCTIONAL STATUS; HEART DISEASE; HEART LEFT VENTRICLE DYSFUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; LOW DRUG DOSE; MYOCARDIAL HIBERNATION; NON INVASIVE PROCEDURE; NONHUMAN; PATHOPHYSIOLOGY; PATIENT CODING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SURVIVAL; SYNDROME;

ALGORITHMS; CHRONIC DISEASE; CORONARY CIRCULATION; DIAGNOSTIC IMAGING; FIBROSIS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TISSUE SURVIVAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 47549086567     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2008.05.009     Document Type: Review

References (88)

1. Warming Winds for Icy Debate. Rapprochement between science and religion may be taking shape (1997) Los Angeles Times, August 17, M4.
2. Rahimtoola S.H. Coronary bypass surgery for chronic angina-1981. A perspective. Circulation 65 (1982) 225-241
3. Rahimtoola S. The hibernating myocardium. Am Heart J 117 (1989) 211-221
4. Ferrari R. Myocardial hibernation. An adaptive phenomenon?. In: Yellon D.M., Rahimtoola S.H., and Opic L.H. (Eds). New Ischemic Syndromes (1997), Authors Publishing House, New York, NY 204-214
5. Carluccio E., Biagioli P., Alunn G., et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol 47 (2006) 969-977
6. Rahimtoola S.H., La Canna G., and Ferrari R. Hibernating myocardium: another piece of the puzzle falls into place. J Am Coll Cardiol 47 (2006) 978-980
7. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 39 (2002) 1151-1158
8. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Prognostic valve of myocardial viability testing: a meta-analysis. Circulation 102 Suppl II (2000) 576
9. Uren N.G., Marraccini P., Gistri R., de Silva R., and Camichi P.G. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol 22 (1993) 650-658
10. Thomas S.A., Fallavollita J.A., Suzuki G., Borgers M., and Canty Jr. J.M. Dissociation of regional adaptations to ischemia and global myolysis in an accelerated swine model of chronic hibernating myocardium. Circ Res 94 (2002) 970-977
11. Gheorghiade M., Sopko G., De Luca, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation 114 (2006) 1202-1213
12. Cleland J.G.F., Pennell D.J., Ray S.G., et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (Christmas trial): randomized controlled trial. Lancet 362 (2003) 14-21
13. Tarakjik G., Brunken R., McCarthy P.M., et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular dysfunction. Circulation 113 (2006) 230-237
14. Heusch G., Schulz R., and Rahimtoola S.H. Myocardial hibernation: a delicate balance. Am J Physiol Heart Circ Physiol 228 (2005) H984-H999
15. Vatner S.F. Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res 47 (1980) 201-207
16. Gallagher K.P., Matsuzaki M., Koziol J.A., Kemper W.S., and Ross Jr. J. Regional myocardial perfusion and wall thickening during ischemia in conscious dogs. Am J Physiol 247 (1984) H727-H738
17. Pantely G.A., Malone S.A., Rhen W.S., et al. Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ Res 67 (1990) 1481-1493
18. Schulz R., Rose J., Martin C., Brodde O.E., and Heusch G. Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation 88 (1993) 684-695
19. Fallavollita J.A., Perry B.J., and Canty J.M. 18-F-2 deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation 95 (1997) 1900-1909
20. Edward N.C., Sinusas A.J., Bergin J.D., Watson D.D., Ruiz M., and Beller G.A. Influence of subendocardial ischemia on transmural myocardial function. Am J Physiol Heart Circ Physiol 262 (1992) H568-H576
21. Bache R.J., Cobb F.R., and Greenfield Jr. J.C. Myocardial blood flow distribution during ischemia-induced coronary vasodilatation in the un-anesthetized dog. J Chin Invest 54 (1974) 1462-1472
22. Heusch G. Hibernating myocardium. Physiol Rev 78 (1998) 1055-1085
23. 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion. Circulation 99 (1999) 2798-2805
24. Selvanayagam J.B., Jerosch-Herold M., Porto I., et al. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation 112 (2005) 3289-3296
25. Klocke F.J. Resting blood flow in hypocontractile myocardium: resolving the controversy. Circulation 112 (2005) 3222-3224
26. Afridi I., Kleiman N.S., Raizner A.E., and Zoghbi W.A. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91 (1995) 663-670
27. Borgers M., Thoné F., Wouters L., Ausma J., Shivalkar B., and Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation?. Cardiovasc Pathol 2 (1993) 237-245
28. Shimoni S., Frangogiannis N.G., Aggeli C.J., et al. Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernation. Circulation 106 (2002) 950-956
29. Lang R.M., Mor-Avi V., Sugeng L., Nieman P.S., and Sahn D.J. Three-dimensional echocardiography: the benefits of the additional dimension. J Am Coll Cardiol 48 (2006) 2053-2069
30. Cwajg J.M., Cwajg E., Nagueh S.F., et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 35 (2000) 1152-1161
31. La Canna G., Rahimtoola S.H., Visioli O., et al. Sensitivity, specificity and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J 21 (2000) 1358-1367
32. Chan J., Hanekom L., Wong C., Leano R., Cho G.Y., and Marwick T.H. Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and long-axis myocardial function. J Am Coll Cardiol 48 (2006) 2026-2033
33. Penicka M., Tousek P., De Bruyne B., et al. Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization. Eur Heart J 28 (2007) 1366-1373
34. Wu K.C., and Lima J.A. Noninvasive imaging of myocardial viability: current techniques and future developments. Circ Res 93 (2003) 1146-1158
35. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age and contractile function. Circulation 100 (1999) 1992-2002
36. Rehwald W.G., Fieno D.S., Chen E.L., Kim R.J., and Judd R.M. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105 (2002) 224-229
37. Mankad S., Khalil R., and Kramer C.M. MRI for the diagnosis of myocardial ischemia and viability. Curr Opin Cardiol 18 (2003) 351-356
38. Wagner A., Mahrholdt H., Holly T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003) 374-379
39. Klein C., Nekolla S.G., Bengel F.M., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105 (2002) 162-167
40. Kuhl H.P., der Weerdt A.V., Beek A.M., Visser C.A., Hanrath P., and van Rossum A.C. Relation of end-diastolic wall thickness and the residual rim of viable myocardium by magnetic resonance imaging to myocardial viability assessed by fluorine-18 deoxyglucose positron emission tomography. Am J Cardiol 97 (2006) 452-457
41. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
42. Knuesel P.R., Nanz D., Wyss C., et al. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 108 (2003) 1095-1100
43. Schvartzman P.R., Srichai M.B., Grimm R.A., et al. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction. Am Heart J 146 (2003) 535-541
44. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 215-223
45. Kellman P., Arai A.E., McVeigh E.R., and Aletras A.H. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med (2002) 372-383
46. Foo T.K., Wolff S.D., Gupta S.N., and Kraitchman D.L. Enhanced viability imaging: Improved contrast in myocardial delayed enhancement using dual inversion time subtraction. Magn Reson Med 53 (2005) 1484-1489
47. Kellman P., Chung Y.-C., Simonetti O., McVeigh E.R., and Arai A.E. Multicontrast delayed enhancement provides improved contrast between myocardial infarction and blood pool. J Magn Reson Imaging 22 (2005) 605-613
48. Sievers B., Elliott M.D., Hurwitz L.M., et al. Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation 115 (2007) 236-244
49. 18F-fluorodeoxyglucose in patients with chronic coronary artery disease. Circulation 91 (1995) 1006-1015
50. Baer F.M., Theissen P., Schneider C.A., et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 31 (1998) 1040-1048
51. Zaret B.L., Strauss H.W., Martin N.D., Wells H.P., and Flamm M.D. Noninvasive regional myocardial perfusion with radioactive potassium: study of patients at rest with exercise and during angina pectoris. N Engl J Med 288 (1973) 809-812
52. Pohost G.M., Zir L.M., Moore R.H., McKusick K.A., Guiney T.E., and Beller G.A. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 55 (1977) 294-302
53. Kiat H., Berman D.S., Maddahi J., et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol 12 (1988) 1456-1463
54. Gewirtz H., Beller G.A., Strauss H.W., et al. Transient defects of resting thallium scans in patients with coronary artery disease. Circulation 59 (1979) 707-713
55. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function. Circulation 87 (1993) 1630-1641
56. Dilsizian V., Rocco T.P., Freedman N.M., Leon M.B., and Bonow R.O. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 323 (1990) 141-146
57. Kitsiou A.N., Srinivasan G., Quyyumi A.A., Summers R.M., Bacharach S.L., and Dilsizian V. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization?. Circulation 98 (1998) 501-508
58. Bax J.J., Poldermans D., Elhendy A., Boersma E., and Rahimtoola S.H. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 26 (2001) 141-186
59. Bax J.J., Wijns W., Cornel J.H., Visser F.C., Boersma E., and Fioretti P.M. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 30 (1997) 1451-1460
60. Bisi G., Sciagra R., Santoro G.M., et al. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 36 (1995) 1994-2000
61. 99mTc-sestamibi. Circulation 89 (1994) 2552-2561
62. Levine M.G., McGill C.C., Ahlberg A.W., et al. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 83 (1999) 1-5
63. 18F-fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?. Circulation 97 (1998) 843-850
64. Taegtmeyer H., and Dilsizian V. Imaging myocardial metabolism and ischemic memory. Nat Clin Pract Card Suppl (2008) In press
65. Tillisch J.H., Brunken R., Marshall R., et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314 (1986) 884-888
66. Tamaki N., Yonekura Y., Yamashita K., et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 64 (1989) 860-865
67. Luciganani G., Paolini G., Landoni C., et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18-fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 19 (1992) 874-881
68. Nienaber C.A., Brunken R.C., Sherman C.T., et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 18 (1991) 966-978
69. Marwick T.H., MacIntyre W.J., LaFont A., Nemec J.J., and Salcedo E.E. Metabolic responses of hibernating and infarcted myocardium to revascularization: a follow-up study of regional perfusion, function, and metabolism. Circulation 85 (1992) 1347-1353
70. vom Dahl J., Eitzman D.T., Al-Aouar Z.R., et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 90 (1994) 2356-2366
71. Flameng W.J., Shivalkar B., Spiessens B., et al. PET scan predicts functional recovery of left ventricular function after coronary artery bypass operation. Ann Thorac Surg 64 (1997) 1694-1701
72. Gerber B.L., Ordoubadi F.F., Wijns W., et al. Positron emission tomography using (18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community concerted action multicenter study on use of (18)F-fluoro-deoxyglucose positron emission tomography for the detection of myocardial viability. Eur Heart J 22 (2001) 1691-1701
73. Eitzman D., Al-Aouar Z., Kanter H., et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 20 (1992) 559-565
74. Di Carli M.F., Davidson M., Little R., et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 73 (1994) 527-533
75. Di Carli M.F., Asgarzadie F., Schelbert H.R., et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 92 (1995) 3436-3444
76. Kawai Y., Tsukamoto E., Nozaki Y., et al. Significance of reduced uptake of iodinated fatty acid analogues for the evaluation of patients with acute chest pain. J Am Coll Cardiol 38 (2001) 1888-1894
77. 123I]-iodophenyl-pentadecanoic acid (BMIPP) identifies ischemic memory following demand ischemia. Circulation 112 (2005) 2169-2174
78. Pasquet A., Lauer M.S., Williams M.J., Secknus M.-A., Lytle B., and Marwick T.H. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism. Eur Heart J 21 (2000) 125-136
79. Hoffmann R., Altiok E., Nowak B., et al. Strain rate measurement by Doppler echocardiography allows improved assessment of myocardial viability inpatients with depressed left ventricular function. J Am Coll Cardiol 39 (2002) 443-449
80. Hanekom L., Jenkins C., Jeffries L., et al. Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization. Circulation 112 (2005) 3892-3900
81. Geskin G., Kramer C.M., Rogers W.J., et al. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 98 (1998) 217-223
82. Samady H., Choi C.J., Ragosta M., Powers E.R., Beller G.A., and Kramer C.M. Electromechanical mapping identifies improvement in function and retention of contractile reserve after revascularization in ischemic cardiomyopathy. Circulation 110 (2004) 2410-2416
83. Wellnhofer E., Olariu A., Klein C., et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 109 (2004) 2172-2174
84. Kim R.J., and Manning W.J. Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?. Circulation 109 (2004) 2476-2479
85. Bove C.M., DiMaria J.M., Voros S., Conaway M.R., and Kramer C.M. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting-initial experience. Radiology 240 (2006) 835-841
86. Schinkel A.F., Bax J.J., Poldermans D., Elhendy A., Ferrari R., and Rahimtoola S.H. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 32 (2007) 375-410
87. Bonow R.O. Comments. Curr Probl Cardiol 32 (2007) 381
88. Dilsizian V. Cardiac magnetic resonance versus SPECT: are all non-infarct myocardial regions created equal?. J Nucl Card 14 (2007) 9-14